Shares in American biotech company Gilead Sciences Inc. climbed to a more than six-month high this week on news that it had been given the green light to start human trials of an experimental antiviral drug on coronavirus patients in China.
Shares in American biotech company Gilead Sciences Inc. climbed to a more than six-month high this week on news that it had been given the green light to start human trials of an experimental antiviral drug on coronavirus patients in China.
007比分 |
彩赢娱乐平台 |
中国体育竞彩网页 |
五福彩票首页注册 |
中博的彩舒适 |
富鱼彩票登录 |
www.yf5599www.vwin |
黄金8彩票登录大厅 |
惠赢竞彩app |